Unsuccessful CTL transfusion in a case of post-BMT Epstein–Barr virus-associated lymphoproliferative disorder (EBV-LPD) (original) (raw)

• Case Report
• Published: 01 August 1997

Bone Marrow Transplantation volume 20, pages 337–340 (1997)Cite this article

• 282 Accesses
• 33 Citations
• Metrics details

Abstract

A patient with AML (FAB M4Eo) developed EBV-LPD 1.5 months after allogeneic BMT from his one locus-mismatched mother, the diagnosis being confirmed on day +82. Attempts to eradicate the monoclonally proliferating LPD using chemotherapy (VP16/dexa- methasone) followed by two doses of EBV-specific CTL and one dose of unstimulated donor leukocytes were not successful. We assume delay of infusions (day +100, +107) and insufficient CTL cell doses (total 9.2 × 106) may have been responsible for the poor outcome in this case.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 12 print issues and online access

$259.00 per year

only $21.58 per issue

Buy this article

• Purchase on SpringerLink
• Instant access to full article PDF

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

• Log in
• Learn about institutional subscriptions
• Read our FAQs
• Contact customer support

Similar content being viewed by others

Author information

Authors and Affiliations

1. Division of Pediatrics, Children’s Research Hospital, Kyoto Prefectural University of Medicine, Kawaramachi, Kamigyo-ku, Kyoto, Japan
   S Imashuku, S Hibi & S Todo
2. Department of Pediatrics, Kyoto Prefectural University of Medicine, Kawaramachi, Kamigyo-ku, Kyoto, Japan
   T Goto, T Matsumura, S Hibi & S Todo
3. Division of Pediatrics, Kyoto City Hospital, Kyoto, Japan
   S Imashuku, M Naya, M Yamori & M Hojo

Authors

1. S Imashuku
2. T Goto
3. T Matsumura
4. M Naya
5. M Yamori
6. M Hojo
7. S Hibi
8. S Todo

Rights and permissions

About this article

Cite this article

Imashuku, S., Goto, T., Matsumura, T. et al. Unsuccessful CTL transfusion in a case of post-BMT Epstein–Barr virus-associated lymphoproliferative disorder (EBV-LPD).Bone Marrow Transplant 20, 337–340 (1997). https://doi.org/10.1038/sj.bmt.1700883

Download citation

• Received: 13 December 1996
• Accepted: 19 April 1997
• Issue Date: 01 August 1997
• DOI: https://doi.org/10.1038/sj.bmt.1700883

Keywords

This article is cited by

• Viral-specific T-cell transfer from HSCT donor for the treatment of viral infections or diseases after HSCT

  • C Qian
  • Y Wang
  • D Bensoussan
    Bone Marrow Transplantation (2018)

• Virus-Specific T Cells for Hematopoietic Stem Cell Transplantation

  • Hema Dave
  • Catherine Bollard
    Current Stem Cell Reports (2017)

• T-cell therapy in the treatment of post-transplant lymphoproliferative disease

  • Catherine M. Bollard
  • Cliona M. Rooney
  • Helen E. Heslop
    Nature Reviews Clinical Oncology (2012)

• Immunotherapy for EBV-associated malignancies

  • Anna Merlo
  • Riccardo Turrini
  • Antonio Rosato
    International Journal of Hematology (2011)

• Adoptive cellular immunotherapy for viral diseases

  • Y Fujita
  • C M Rooney
  • H E Heslop
    Bone Marrow Transplantation (2008)